Posts

March 26, 2015

+
12:48 AM | brucesterling:*Nothing to see here That’s just scientific fact. 
brucesterling:*Nothing to see here That’s just scientific fact. 
+
12:01 AM | Teva appoints Timothy Wright as business development head
The former Covidien Pharma president most recently led a US cancer centre

March 25, 2015

+
8:10 PM | Big Pharma vaccine profits – the real conspiracy
The Skeptical Raptor, stalking pseudoscience in the internet jungle. Updated 25 March 2015 One of the ongoing memes, tropes and fabrications of the vaccine deniers is somehow, somewhere, in some Big Pharma boardroom, a group of men and women in suits choose the next vaccine in some magical way, and foist it upon the world just to make billions of dollars. And while magically concocting … Continue reading Big Pharma vaccine profits – the real conspiracy →Continue reading […]
+
4:30 PM | Judge a Man by His Fingers: Digit Ratios May Predict Behavior...
Judge a Man by His Fingers: Digit Ratios May Predict Behavior Toward WomenSo, frankly, I’m a bit skeptical. (Maybe I’m a bit closed-minded.) But this study seems to have found a correlation and some research to suggest a viable link. That said, I do find it interesting, even if just as an idea. Highlights:Maybe you should take a good look at your partner’s fingers before putting a ring on one. Men with short index fingers and long ring fingers are on average nicer towards […]
+
3:56 PM | Promega Art Showcases Explore Creativity, Science and the Unknown
Albert Einstein once wrote: “to raise new questions, new possibilities, to regard old problems from a new angle requires creative imagination and marks real advances in science.” The marriage of science and creativity, it seems, is indispensable for exploration and the discovery of new ideas. As a life sciences company, Promega supports the work of […]
+
3:30 PM | Genome-Wide DNA Methylome Analysis Reveals Epigenetically Dysregulated Non-coding RNAs in Human Breast Cancer
Yongsheng Li, Yunpeng Zhang, Shengli Li, Jianping Lu, Juan Chen, Yuan Wang, Yixue Li, Juan Xu, Xia Li The development of human cancer is mediated by both genetic and epigenetic alterations of the cell. Since the discovery of altered DNA methylation in human cancer, DNA methylation studies of cancer have ... The post Genome-Wide DNA Methylome Analysis Reveals Epigenetically Dysregulated Non-coding RNAs in Human Breast Cancer appeared first on EpiBeat.
+
1:38 PM | Video Tip of the Week: Protein structure information for public outreach. Really.
This week’s tip isn’t about a specific tool–but a really interesting look at how a tool was used in the context of some general public outreach messaging. Recently I posted about Aquaria, a new tool available to let biologists explore protein structures, mutations, and domains in user-friendly ways. But an interesting example of how the […]

O'Donoghue S.I., Maria Kalemanov, Christian Stolte, Benjamin Wellmann, Vivian Ho, Manfred Roos, Nelson Perdigão, Fabian A Buske, Julian Heinrich & Burkhard Rost & (2015). Aquaria: simplifying discovery and insight from protein structures, Nature Methods, 12 (2) 98-99. DOI: http://dx.doi.org/10.1038/nmeth.3258

Citation
+
1:00 PM | Steve Wozniak, Co-Founder of Apple, is now also Warning of the...
Steve Wozniak, Co-Founder of Apple, is now also Warning of the Potential Dangers of Advanced RoboticsBasically, it could make humans superfluous - which could mean a utopia where no-one needs to work, or it could mean a dystopia where no-one can find work.
+
12:00 PM | Update from the Clinic: February
. Welcome to your Update from the Clinic for the month of February. Northwest Biotherapeutics received approval from Health Canada to proceed with its ongoing Phase 3 clinical study in Glioblastoma multiforme at clinical sites in Quebec. Sangamo and bluebird bio both had news on the regulatory progress of their respective beta-thalassemia programs. Kite Pharma...Read more
+
10:39 AM | AZ links with Harvard for diabetes research
Firm extends ties with the highly respected academic institution in hope of finding innovative leads
+
10:20 AM | Merck's Keytruda beats BMS' Yervoy in melanoma face-off
Both firms competing for a leading share in the highly competitive skin cancer drug market
+
9:22 AM | Novo Nordisk sheds autoimmune portfolio to BMS
Continues the trend of pharma buying up unwanted assets from rival firms
+
8:37 AM | Cancer charity partners with research council for innovation
CRUK teams up with multi-disciplinary groups to help develop new oncology products
+
12:18 AM | Mi Reino por un ADN!
Identification of the remains of King Richard III.Nature Communications 5, Article number: 5631 doi:10.1038/ncomms6631, 2014.Ricardo III (1452-1485)
+
12:02 AM | Seismic shifts: Hepatitis C and payers
How hep C is causing paradigm changes in payer behaviour
+
12:02 AM | EMA elects Dr Christa Wirthumer-Hoche new vice chair
Head of the Austrian regulator succeeds Prof Dr Walter Schwerdtfeger

March 24, 2015

+
7:41 PM | Most published medical research is a failure – it’s not what you think
The Skeptical Raptor, stalking pseudoscience in the internet jungle. Yes, you read that right. This so-called shill for the pharmaceutical industry is calling them as I see them–most published medical research articles present information that is eventually a failure. Now by failure I mean that more often than not, claims that are supported by one or two published articles, rarely lead to a marketed product. I … Continue reading Most published medical research is a […]
+
4:30 PM | thebrainscoop:dendroica:Museums: The endangered dead Across the...
thebrainscoop:dendroica:Museums: The endangered dead Across the world, natural-history collections hold thousands of species awaiting identification. In fact, researchers today find many more novel animals and plants by sifting through decades-old specimens than they do by surveying tropical forests and remote landscapes. An estimated three-quarters of newly named mammal species are already part of a natural-history collection at the time they are identified. They sometimes sit unrecognized for […]
+
2:18 PM | Revolution Bioengineering Chat Recap
Thanks everyone for joining us today during our chat with Keira Havens and Nikolai Braun from Revolution Bioengineering. In case you missed it, want to watch it again, or share...
+
2:18 PM | Revolution Bioengineering Chat Recap
Thanks everyone for joining us today during our chat with Keira Havens and Nikolai Braun from Revolution Bioengineering. In case you missed it, want to watch it again, or share...
+
1:29 PM | Such a long journey – Europe approves retinal cell therapy based on decades of good science
> At one of my very first Canadian Stem Cell Network Annual General Meetings, when I was just a couple of years into my stem cell biology training, I remember sitting down just after lunch when a jovial Italian man sauntered up to the stage and apologized to the audience for the timing of his...Read more
+
11:25 AM | Dendreon wins IQWiG U-turn for its immunotherapy Provenge
New data for its troubled cancer drug convinces German HTA body of its added benefit
+
11:07 AM | Lilly/Boehringer's diabetes combination Glyxambi debuts in US
Companies launch first fixed-dose of empagliflozin and linagliptin
+
10:32 AM | Pfizer and Lilly restart tanezumab pain trials
FDA lifts clinical block on late-stage studies of the novel painkiller
+
10:24 AM | Takeda spends $230m on oncology biotech deal
Buys into ImmunoGen’s antibody-drug conjugate technology
+
10:18 AM | India achieved only 1.4% ethanol blending this fiscal year
Problems between sugar mill owners and oil marketing companies have resulted in only 1.4% ethanol blending through february this fiscal year which is way less than the blending target of 5% and lesser than the last year’s achieved blending level of 2%.The National Policy on Biofuels of India identifies the sugar cane molasses as the feedstock suitable under Indian conditions for ethanol production for blending purpose and that makes the sugarcane mills as the biggest […]
+
7:00 AM | Merck KGaA supports Get Tested colorectal cancer campaign
Coincides with the first World Metastatic Colorectal Cancer Day
+
12:03 AM | The end of hepatitis C?
Next-gen hep C therapies may see the disease's global elimination - but treament access must be stepped up dramatically
+
12:03 AM | The Purple Agency appoints Andrew Jenkins and Terri Martin
Jenkins joins from FTI Strategic Communications and Martin comes from Porterhouse
+
12:02 AM | FDA grants orphan drug status to Treeway's ALS treatment
Amyotrophic Lateral Sclerosis drug TW001 gains regulatory benefits
123456789
422 Results